Showing results (21-30 of 284) with videos related to
Sort By:
Pageof 29
Experimental Hematology|September 1, 1988
Circadian and seasonal rhythms in murine bone marrow colony-forming cells affect tolerance for the anticancer agent 4'-O-tetrahydropyranyladriamycin (THP)F Lévi, I Blazsek, A Ferlé-VidovicBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1991
Modulation of bone marrow cell functions in vitro by bestatin (ubenimex)I Blazsek, M Comisso, J L MissetCancer Detection and Prevention. Supplement : Official Publication of the International Society for Preventive Oncology, Inc|January 1, 1987
Passive, adoptive, and active immunotherapy: a review of clinical trials in cancerG MathéBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1985
[Prevention of genito-anal and bucco-laryngo-esophageal cancers caused by sexually transmitted viruses]G MathéBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 16, 2000
Can Langerhans cell UV injury and dendritic cell infection by immunosuppressive viruses induce immunologic tolerance? First partG MathéBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1997
Hypothetical reasons of the HIV1-AIDS "tritherapy" failure. A challenging modelG MathéBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1995
Can an adjuvant treatment or a pharmacologic prevention be common to several diseases? The case of those associated to neuromediator defectsG MathéBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
Will killing the last HIV1 particle cure AIDS patients? Doesn't CMV activation and/or a graft-versus-host component of the disease, also have to be considered? I. First of two partsG MathéBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 9, 2000
Why have ten or so nontoxic, retrovirus integrase inhibitors not been made available for AIDS treatment? A ten-year experience [correction of experiment] must liberate themG MathéBiomedicine / [Publiee Pour L'A.A.I.C.I.G.]|December 1, 1977
Integration of modern data in W.H.O. categorisation of lymphosarcomas. Its value for prognosis prediction and therapeutic adaptation to prognosisG MathéPageof 29